$WMT

Stocks making the biggest moves midday: Walmart, Deere, CrowdStrike, Moderna & more

Walmart (WMT) fell 9% as Q2 revenue beat estimates but same-store sales and EPS guidance missed. Deere (DE) rose 9% after Q3 earnings and revenue topped estimates, raising full-year guidance. Webull (WB) gained 4% with Q2 adjusted operating income and revenue beating expectations. Crypto-related stocks like Coinbase (COIN) and Mara Holdings (MARA) climbed 7-12% following Bitcoin and Ether's surge. Moderna (MRNA) plunged 25% after a 177% gain, as trial results for a skin cancer vaccine were met w

Original reporting
Published Aug 20, 2026, 6:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 20, 2026, 6:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Stocks making the biggest moves midday: Walmart, Deere, CrowdStrike, Moderna & more — source image
Decision brief

The 30-second read

$WMTBearishMed
01

Why it matters

Multiple companies reported fresh earnings and guidance, driving significant intraday price swings.

02

Market read

The article provides first‑report earnings data for several large caps, creating actionable trading opportunities.

03

What to watch

Supply‑chain pressures on Walmart and Deere, regulatory scrutiny on crypto could affect longer‑term trends.

Relevance 7/10Novelty 7/10Timing: midday today

Background

Midday market roundup highlighting earnings releases and sector moves.

Company-level read

Ticker impact

$WMTBearishMedium confidence
Context

Walmart reported Q2 revenue beat but same-store sales and EPS guidance missed expectations, causing a 9% drop.

Expected impact

Potential continued downside toward support around $140.

Evidence & confidence

Guidance shortfall and sales miss suggest near-term weakness.

$DEBullishMedium confidence
Context

Deere posted Q3 EPS $5.10 vs $4.70 estimate and raised full-year net income guidance, sending shares up ~9%.

Expected impact

May test resistance near $150.

Evidence & confidence

Beat and guidance lift suggest further upside.

$COINBullishLow confidence
Context

Coinbase gained about 8% as crypto stocks rallied on Bitcoin and Ether price surge.

Expected impact

Potential move toward $80 resistance.

Evidence & confidence

Move driven by broader crypto sentiment, not company‑specific news.

$RIGBullishMedium confidence
Context

Transocean rose 2% after signing a $300 million two‑year contract with ONGC for an ultra‑deepwater drillship.

Expected impact

May test near $30 resistance.

Evidence & confidence

Contract size is material for the sector.

$MRNABearishMedium confidence
Context

Moderna plunged 25% after a prior 177% rally, despite late‑stage skin‑cancer vaccine trial meeting key goals.

Expected impact

Potential further decline toward $70 support.

Evidence & confidence

Market re‑prices after large prior rally.

$NDSNBullishMedium confidence
Context

Nordson raised full‑year adjusted earnings guidance to $11.80‑$12, beating consensus, sending shares up ~7%.

Expected impact

May test resistance near $140.

Evidence & confidence

Guidance lift is material for valuation.

$AAPBearishMedium confidence
Context

Advance Auto Parts fell 25% after mixed Q2 results, with revenue miss and same‑store sales decline.

Expected impact

Potential move toward $120 support.

Evidence & confidence

Weak top‑line and sales data suggest near‑term weakness.

$COTYBearishMedium confidence
Context

Coty dropped 9% after reporting a larger quarterly loss and labeling fiscal 2027 a "transition year."

Expected impact

May test support near $30.

Evidence & confidence

Guidance and loss miss are negative catalysts.

Market effects

Earnings beats and misses across industrials, consumer discretionary, and tech influence sector rotation.

U.S. equities show mixed reactions; crypto rally lifts related stocks.

Broad market move reflects earnings season and crypto sentiment globally.

Counterpoint

Some beaten‑down names like Walmart may rebound if guidance improves; crypto stocks could reverse if Bitcoin stalls.

Key entities

  • Walmart

    Retail giant with earnings miss.

  • Deere

    Agricultural equipment maker with earnings beat.

Related articles

$CRWDMedAI 8/10

Jim Cramer Highlights CrowdStrike (CRWD) as AI Security Concerns Lift Cybersecurity Stocks

CrowdStrike (CRWD) rose 14% after Jim Cramer highlighted its AI-driven cybersecurity opportunities. Q2 revenue grew 26% to $1.47B, with ARR up 25% to $5.84B. The company raised its full-year net new ARR growth outlook to 34%. CEO George Kurtz emphasized AI threats and CrowdStrike's solutions. The stock's high valuation (forward P/E 188.7x) leaves little room for growth slowdowns.

$WMTMedAI 8/10

Walmart is accelerating its battle against Amazon with a weapon that the e-commerce giant cannot copy: more than 4,000 stores

Walmart reported a 23% increase in global eCommerce sales for Q2 2027, with U.S. online sales up 24%. The company leverages its 4,615 U.S. stores for last-mile deliveries, with 80% of eCommerce orders fulfilled through stores. Marketplace sales grew 52%, and advertising revenue increased 38%. Walmart aims to integrate physical and digital operations to compete with Amazon.

$COINMedAI 8/10

SEC opens door to tokenized U.S. stock trading. Here’s who could benefit

The SEC introduced a five-year exemption for tokenized U.S. stocks, benefiting firms like Securitize, Bullish, and Superstate. Tokenized stocks must represent actual shares with full rights, excluding synthetic products from Robinhood, Kraken, and Ondo. The move also opens a regulated path for DeFi platforms like Uniswap and blockchains including Ethereum, Solana, and BNB Chain, subject to KYC and other guardrails. Public companies have a 30-day veto right over tokenization of their shares. Secu

$MRNAHighAI 8/10

MRNA Looks 558.1% Overvalued on GF Value™

Moderna Inc. (MRNA) shares rose 9% to $158.07 on positive Phase 3 oncology trial results, adding to a 177% surge since August. The company's P/S ratio is 28, well above its historical median and industry norms, indicating high growth expectations. Moderna's GF Value™ suggests it is 558.1% overvalued, with a GF Score™ of 58 out of 100, reflecting mixed fundamentals. Insiders sold $64.6 million in shares, while institutional activity is mixed.

$COINMed

The CLARITY Act Fails 50 to 49: What’s Next for XRP, Bitcoin, Ethereum, and Solana Now That Congress Is Done for the Year?

The CLARITY Act failed in the Senate with a 49-50 vote, falling short of the 60 needed for passage. XRP dropped 7.98% to $1.29, while Bitcoin fell 1.42% to $75,924. Coinbase and Circle shares declined 8% and 11% respectively. The act's failure leaves regulatory uncertainty for cryptocurrencies, with their values now dependent on SEC initiatives and market conditions.

$COINHigh

The SEC Steps In to Ease Crypto’s Path After Big Legislative Loss

The SEC introduced a five-year exemption to securities laws to enable trading of tokenized stocks, following Congress' failure to pass the Clarity Act. This move aims to support digital assets and follows a 48-hour turnaround. Bitcoin and crypto-linked stocks like Coinbase (COIN), Robinhood (HOOD), and Circle (CRCL) saw gains.